Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sarcoma × Dexamethasone × Clear all

Phase

Phase NA 2 Phase 1 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 136 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Vomiting 22 Recurrence 21 Leukemia 20 Neoplasms, Plasma Cell 17 Neoplasms 16 Nausea 12 Lymphoma 12 Prostatic Neoplasms 8 Burkitt Lymphoma 7 Immunoglobulin Light-chain Amyloidosis 6 Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, Follicular 4 Hodgkin Disease 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Paraproteinemias 3 Lymphoma, Non-Hodgkin 3 Fallopian Tube Neoplasms 3 Smoldering Multiple Myeloma 2 Plasmacytoma 2 Lymphoproliferative Disorders 2 Lymphoma, Mantle-Cell 2

Interventions

Doxorubicin 22 Ifosfamide 19 Radiotherapy 14 Vincristine 9 Etoposide 9 Filgrastim 8 Cyclophosphamide 8 Trabectedin 7 Dactinomycin 7 pazopanib 4 Cisplatin 4 Topotecan 3 Radiation 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Chemotherapy, Adjuvant 3 sargramostim 2 etoposide phosphate 2 eribulin 2 Observation 2 Methotrexate 2 Mesna 2 Imatinib Mesylate 2 Gemcitabine 2 Docetaxel 2 Dexrazoxane 2 Dacarbazine 2 trofosfamide 1 trioctyl phosphine oxide 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02672527 2018-08-16

TSAR

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡